Microbix Biosystems Inc. Gets U.S. Flu Vaccine Patent

October 22, 2007 |

1 min read

Microbix Biosystems Inc. (TSX: MBX) has been granted a U.S. patent for its Virusmax influenza vaccine production-enhancement technology.